Telewound Care Canada
Using AI to deliver remote wound care to the most vulnerable patients.
Project Overview
Updated October 31, 2023
The Problem
Wounds are a huge challenge to the healthcare system.
More than 6.5 million people in North America have chronic wounds that require ongoing care. In Canada, 30 to 50 per cent of all healthcare involves a wound, amounting to an annual spend of $3.9 billion on direct wound care costs. Without regular care, patients can face infections that drive hospitalization, amputation and even death. Wound care is also complex, has a high error rate due to antiquated tools in measuring severity, and most physicians receive less than 10 hours of formal wound care education while in school.
Throughout the COVID-19 pandemic and as an ongoing issue for rural or remote communities, many vulnerable wound patients were under quarantine or without geographic access to vital wound care they need. If essential care is postponed or improperly delivered, patients are 20 times likely to end up in hospital and 10 to 40 times more likely to need an amputation.
While many healthcare organizations adopted virtual care solutions to reach patients during COVID-19, telehealth solutions were initially inadequate for wound care. The solutions lacked the high resolution, scientifically calibrated images, sub-millimeter accuracy and proper lighting that are critical to remotely assessing and treating wounds.
How We Are Solving It
The Telewound Care Canada project sought to develop and deploy a technology solution that enables patients to access wound care from their own home, without having to risk exposure to COVID-19 during the pandemic.
Led by Swift Medical, the project brought together SE Health, AlayaCare and several healthcare and academic institutions in Canada.
The initiative sought to provide a mobile application that can be used by patients to take pictures of their wound, share them with their healthcare provider and conduct a virtual consultation – all while allowing providers to gain visibility into healing trends, risks and needs. Health professionals can remotely review medical-grade wound images with new imaging AI, which also helps to document, assess and treat those wounds. The platform would be able to quantify and forecast the risk of new or worsening wounds, enabling care providers to deliver proactive and preventive care that will help keep patients healthy at home.
Beyond the COVID-19 crisis, the technology cited its potential to improve wound care worldwide by enabling patients to access quality wound care from anywhere.
The Result
This project delivered the Telewound Care solution, which enables enhanced access to wound care for patients in the home and community to support better treatment decisions and earlier identification of high risk wound patients to drive proactive intervention — and keep them in their home. The solution is a mobile application that allows patients or clinicians to easily take wound images and share these images/data with the entire healthcare team to support continuous, convenient and preventive care.
The solution is considered the #1 digital wound care solution with Swift Medical being ranked one of the most promising digital health startups in the world by CB Insights. It has been adopted by ~4,000 healthcare facilities and 20,000 users with 200,000 active patients under care, with outcomes showing 95% clinical accuracy, a 50% reduction of readmissions, decreased length of stay by 4 months and reduced costs by >$1,000 per patient per month.
Dr. Sheila Wang, co-founder and Chief Medical Officer of Swift Medical, also received Canada’s Governor General’s Innovation Award in 2021 for their advancements and leadership in remote wound care.
Project Lead
Project Partners
-
"The 2019 funding from DIGITAL of the Telewound Care Canada project helped Swift navigate a challenging year during COVID and continue to make gains in our technology and adoption, which contributed to investor confidence in our company. DIGITAL was truly one of our most instrumental partners leading to our Series B in 2021, helping us develop innovative partnerships and launch new technologies that are having a meaningful impact on patients across Canada and the US. Doubtless to say, we would not be in the strong position we are today without the support of DIGITAL."
VP Clinical Innovation, Swift Medical -
"The Supercluster has been instrumental in our ability to develop new innovative technologies, transform these technologies into novel IP and product offerings, and commercialize them at scale in Canada and internationally. As a direct result of our Supercluster project, almost 2,000 patients have been able to access digitally-enhanced wound care, which has led to meaningful outcomes, such as over $1,000 in health system cost savings per patient, a reduction in ED visits and readmissions, and an improvement in clinician and patient satisfaction when it comes to wound care."
Founder and CEO of Swift Medical Watch the Swift Medical Video -
“We had one patient who had breast cancer and she had breast surgery on both sides to remove the cancer, and for six years her wounds didn’t close. Now these are difficult to treat and difficult to heal wounds. She started using the Swift technology in January 2021 and now, ten months later, her wounds are fully healed and closed.”
Co-Founder and Chief Medical Officer, Swift Medical Read our Impact Story -
"Working with DIGITAL has greatly accelerated the pace of innovation at Swift Medical, deepening our IP strategy and assets. This has sharpened our competitive edge against global competitors, raised our profile in health technology, and allowed us to provide much more value to our healthcare customers – and ultimately their patients – with the technology we've developed and commercialized through the project."
Co-Founder and Chief Engineer, Swift Medical Watch the Video